Webinar

Bioavailability Enhancement Series – Nanoparticle Dispersions & Drug Nanocyrstals

Format: External webinar | Document type: Webinar

Bioavailability Enhancement Series – Nanoparticle Dispersions & Drug Nanocyrstals
Drug-containing nanoparticles offer the potential for both increased dissolution rate and higher drug activity compared to bulk crystalline drug.  These advantages can improve oral bioavailability of drugs for which absorption is either dissolution-rate-limited (i.e. DCS Class IIa), or solubility-limited (i.e., DCS Class IIb and IV drugs).  In this webinar, the physicochemical properties, in vitro and in vivo performance, and manufacturing considerations for amorphous nanoparticle dispersions and drug nanocrystals for bioavailability enhancement will be explored. 

Speakers

David Vodak David Vodak Vice President, Chemistry
Capsugel

Mike Morgen Mike Morgen Director, New Technology Development
Capsugel

Related resources from Capsugel

Supplier info centre